Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Oxbridge Re Holdings (OXBR) Shares Outstanding (Weighted Average) (2016 - 2025)

Oxbridge Re Holdings (OXBR) has disclosed Shares Outstanding (Weighted Average) for 12 consecutive years, with $7.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 26.77% to $7.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $7.7 million, a 26.77% increase, with the full-year FY2024 number at $6.1 million, up 3.95% from a year prior.
  • Shares Outstanding (Weighted Average) was $7.7 million for Q3 2025 at Oxbridge Re Holdings, up from $7.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $5.7 billion in Q1 2021 to a low of $5.7 million in Q2 2021.
  • A 5-year average of $307.6 million and a median of $5.9 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): surged 99900.0% in 2021, then crashed 99.9% in 2022.
  • Oxbridge Re Holdings' Shares Outstanding (Weighted Average) stood at $5.7 million in 2021, then grew by 0.64% to $5.8 million in 2022, then rose by 1.64% to $5.9 million in 2023, then grew by 3.95% to $6.1 million in 2024, then grew by 25.66% to $7.7 million in 2025.
  • Per Business Quant, the three most recent readings for OXBR's Shares Outstanding (Weighted Average) are $7.7 million (Q3 2025), $7.4 million (Q2 2025), and $6.9 million (Q1 2025).